The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy. Wu H, Shu W, Ding Y, Li Q, et al. BMC Cancer 2025;25:1369.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu H, Shu W, Ding Y, Li Q, et al. The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy. BMC Cancer 2025;25:1369.
PMID: 40851062